Obsidian Therapeutics Stock (NASDAQ:OBX)
Previous Close
$18.40
52W Range
$14.57 - $49.97
50D Avg
$21.89
200D Avg
$21.89
Market Cap
$18.40M
Avg Vol (3M)
$112.44K
Beta
2.64
Div Yield
-
OBX Company Profile
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.